IDH1(R132H) Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells

The R132H mutation in isocitrate dehydrogenase 1 (IDH1(R132H)) is commonly observed and associated with better survival in glioblastoma multiforme (GBM), a malignant brain tumor. However, the functional role of IDH1(R132H) as a molecular target for GBM treatment is not completely understood. In this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Mol Sci
Egile Nagusiak: Kim, Geon-Hee, Choi, So Young, Oh, Taek-In, Kan, Sang-Yeon, Kang, Hyeji, Lee, Sujin, Oh, Taerim, Ko, Hyun Myung, Lim, Ji-Hong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6600637/
https://ncbi.nlm.nih.gov/pubmed/31151327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20112679
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak